NCT00523757View on ClinicalTrials.gov

Aldosterone Blockade in Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Heart Failure
Interventions
DRUG

Spironolactone

DRUG

Placebo

Trial Locations (1)

Unknown

University of Alberta Hospital, Edmonton

All Listed Sponsors
lead

Justin Ezekowitz

OTHER

NCT00523757 - Aldosterone Blockade in Heart Failure | Biotech Hunter | Biotech Hunter